chartexchange

BCRX
BioCryst Pharmaceuticals Inc
stockNASDAQ

At CloseNov 13, 2026 3:59:57 PM EST
7.60USD-1.042%(-0.08)2,315,802
After-hoursNov 13, 2026 4:00:30 PM EST
7.61USD+0.132%(+0.01)

BCRX Financials

In Q3 FY 2026 (ended ), BioCryst Pharmaceuticals Inc (BCRX) reported revenue of $180.29M, net income of $37.92M, operating cash flow of $32.98M, and assets of $591.07M (filed ).

Loading financial statements…